Clinical Trials in Boston

Showing 5961-5980 of 13,548 trials

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

NCT02872701

This is a phase 2, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/positron emission tomography imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary nodules within the operating theater, and to assess the safety and tolerability of single intravenous doses of OTL38.

Lung NeoplasmsLung Cancer

On Target Laboratories, LLC100 participantsStarted May 2017

Boston, Massachusetts, United States • Cleveland, Ohio, United States • Philadelphia, Pennsylvania, United States +3 more locations

TERMINATEDNA< 1 mile

OPTIMIZE IDE for the Treatment of ACS

NCT03190473

Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm

Acute Coronary Syndrome

Svelte Medical Systems, Inc.1,630 participantsStarted Jan 2018

Fairhope, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +69 more locations

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

OPTIMIZE IDE for the Treatment of ACS

Find Trials by Condition in Boston

EdemaWear to Reduce Edema in Hospitalized Patients With CVI:

Assessment of Acute Disease to Reduce Imaging Costs

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Investigating the Impact of Professional Development Coaching for Faculty

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

Fulfillment Center Study on Work, Health, and Wellbeing

Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Integrated Alcohol and Sexual Assault Intervention for College Men

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

The TREFOIL Concept 5 Year Clinical Investigation